Catalase and SOD activity enhancement inskin tumors after 24 weeks of treatment;GSH levels and activity increasein a dose-dependent manner;Reduction in the expression of Rassf7,Nrf2, PARP, and NF-κB genes in a dose-dependent manner;Inhibition of MDA in skin tumors, in a dose-dependent manner, leads to a lipid peroxidation decrease. The gene discussed is NFKB1; the disease is skin neoplasm.